Navigation Links
Senetek PLC Launches Dedicated Pyratine-6(TM) Website
Date:1/27/2009

NAPA, Calif., Jan. 27 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that target the science of healthy aging, announced today the launch of a dedicated Pyratine-6(TM) website, http://www.Pyratine-6.com, that provides information to consumers and medical professionals about Pyratine-6, Senetek's advanced cytokinin technology.

The website (http://www.Pyratine-6.com) is a comprehensive and convenient resource for information on Senetek's anti-aging cytokinin technology and the Pyratine-6(TM) product line, which includes Pyratine-6(TM) Lotion, Creme, Foaming Cleanser, Soft Creme + 10% Vitamin C. An SPF product will be introduced in Spring 2009 to complete the Pyratine-6(TM) line.

Detailed sections provide site visitors with a scientific analysis of cytokinins for therapeutic applications, and present the results of a 12-week independent clinical trial that demonstrates the efficacy of Pyratine-6(TM) for roughness, erythema, hyperpigmentation, skin moisture, and fine wrinkles. Also featured is Senetek's history in the development of innovative skincare technologies, including the cytokinins Kinetin and Zeatin. Additionally, a dedicated physician-only section will soon provide local resources, staff training tools and sales support to the medical community.

"The launch of the Pyratine-6(TM) website allows both consumers and physicians practical, reliable access to cutting-edge anti-aging information and products from Senetek," said Frank Massino, CEO of Senetek PLC. "The straightforward design of the site echoes and supports our research-based, results-driven technology."

About Senetek, PLC

Senetek PLC (OTCBB:SNKTY) is a life sciences company engaged in the development of breakthrough technologies that target the science of healthy aging. The company's extensive research collaborations have resulted in a strong pipeline of patented compounds and products with broad therapeutic applications and a leading presence in dermatology. Senetek collaborates with established specialty pharmaceutical companies in the final development and marketing of its proprietary products, most recently resulting in the development of kinetin, the best-selling anti-aging product sold in the North American physician market. For more information, visit the company's website at http://www.senetekplc.com.


'/>"/>
SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
2. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
3. Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
4. Isogen Launches Major New Facility to Address Global Biopharma Demand
5. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
6. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
7. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
8. Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients
9. Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center
10. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
11. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
Breaking Medicine News(10 mins):